A careful reassessment of anthracycline use in curable breast cancer

It has been over three decades since anthracyclines took their place as the standard chemotherapy backbone for breast cancer in the curative setting. Though the efficacy of anthracycline chemotherapy is not debatable, potentially life-threatening and long-term risks accompany this class of agents, l...

Descripción completa

Detalles Bibliográficos
Autores principales: Hurvitz, Sara Alsterlind, McAndrew, Nicholas P., Bardia, Aditya, Press, Michael F., Pegram, Mark, Crown, John P., Fasching, Peter A., Ejlertsen, Bent, Yang, Eric H., Glaspy, John A., Slamon, Dennis J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501074/
https://www.ncbi.nlm.nih.gov/pubmed/34625570
http://dx.doi.org/10.1038/s41523-021-00342-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501074/
https://www.ncbi.nlm.nih.gov/pubmed/34625570
http://dx.doi.org/10.1038/s41523-021-00342-5

Ejemplares similares